Philip Hopkins
0000-0002-8127-1739
University of Leeds
30 papers found
Refreshing results…
Peripheral regional anaesthesia and outcomes: a narrative review of the literature from 2013 to 2023
An Association between OXPHOS-Related Gene Expression and Malignant Hyperthermia Susceptibility in Human Skeletal Muscle Biopsies
Pholcodine and allergy to neuromuscular blocking agents: where are we and how did we get here?
Comparison of Transcriptomic Changes in Survivors of Exertional Heat Illness with Malignant Hyperthermia Susceptible Patients
Suspected perioperative anaphylaxis: are we making the correct diagnosis?
What is malignant hyperthermia susceptibility?
European Neuromuscular Centre consensus statement on anaesthesia in patients with neuromuscular disorders
Updated variant curation expert panel criteria and pathogenicity classifications for 251 variants for RYR1-related malignant hyperthermia susceptibility
Variants in ASPH cause exertional heat illness and are associated with malignant hyperthermia susceptibility
Epidemiology of perioperative anaphylaxis in the United States: new insights but more to learn and do
DALES, Drug Allergy Labels in Elective Surgical patients: a prospective, multicentre cross-sectional study of prevalence, nature and anaesthetists’ approach to management
Ryanodine receptor leak triggers fiber Ca 2+ redistribution to preserve force and elevate basal metabolism in skeletal muscle
Variant curation expert panel recommendations for RYR1 pathogenicity classifications in malignant hyperthermia susceptibility
Anaesthetic management of a known or suspected malignant hyperthermia susceptible patient
Malignant hyperthermia 2020
Generic versus reference listed ropivacaine for peripheral nerve blockade
Molecular Modification of Transient Receptor Potential Canonical 6 Channels Modulates Calcium Dyshomeostasis in a Mouse Model Relevant to Malignant Hyperthermia
Consensus guidelines on perioperative management of malignant hyperthermia suspected or susceptible patients from the European Malignant Hyperthermia Group
Genomic Screening for Malignant Hyperthermia Susceptibility
Sevoflurane may not be a complete sigh of relief in COVID-19
Missing publications? Search for publications with a matching author name.